Specimen Transport
Articles & Testing Guides
Education
Outreach Resource Center
- Support Services
- Operations
- Sales and Marketing
- Billing and Finance
- Regulatory
- Examples
- More Resources
- Contact Outreach Team
| Web: | MayoMedicalLaboratories.com |
|---|---|
| Email: | mml@mayo.edu |
| Telephone: | 800.533.1710 |
| International: | 507.266.5700 |
| Values are valid only on day of printing. | |
Aiding in the diagnosis of Kallmann syndrome, in conjunction
with conventional chromosome studies (#8696 "Chromosome
Analysis, for Congenital Disorders, Blood")
Detecting cryptic translocations involving Xp22.3 that are not
demonstrated by conventional chromosome studies
Kallmann syndrome is associated with a deletion on the short arm
of the X chromosome. The syndrome is an X-linked disease and
can be suspected in patients with complete absence of smell
(anosmia), hypogonadism, and delayed sexual development.
The phenotype may include gynecomastia, bimanual synkinesis
(1 hand copying the movements of the other hand), shortened 4th
metacarpal bone, and absence of a kidney. Kallmann syndrome
affects mainly males, but rare cases of affected females have
been reported.
Fluorescence in situ hybridization (FISH) studies are highly specific
and do not exclude other chromosome abnormalities. We recommend
that patients suspected of having Kallmann syndrome also have
conventional chromosome studies (#8696 "Chromosome Analysis,
for Congenital Disorders, Blood") performed to rule out other
chromosome abnormalities or translocations.
An interpretive report will be provided.
Any individual with a normal signal pattern (2 signals in females and
1 signal in males) in each metaphase is considered negative for a
deletion in the region tested by this probe.
Any patient with a FISH signal pattern indicating loss of the critical
region on an X chromosome will be reported as having a deletion
of the regions tested by this probe.
Because this FISH test is not approved by the Food and Drug
Administration (FDA), it is important to confirm Kallmann syndrome
diagnoses by other established methods, such as clinical history
or physical examination.
1. Meitinger T, Heye B, Petit C, et al: Definitive localization of X-linked
Kallmann syndrome (hypogonadotropic hypogonadism and anosmia)
to Xp22.3: close linkage to the hypervariable repeat sequence
CRI-S232. Am J Hum Genet 1990 Oct;47(4):664-669
2. Weissortel R, Strom TM, Dorr HG, et al: Analysis of an interstitial
deletion in a patient with Kallmann syndrome, X-linked ichthyosis
and mental retardation. Clin Genet 1998 Jul;54(1):45-51